Autor(es)

Frohlich, Alek ; Ramos, Thiago ; Cabello Dos Santos, Gustavo Motta ; Carlotti Buzatto, Isabela Panzeri ; Izbicki, Rafael ; Tiezzi, Daniel Guimaraes

• Tipo de documento: Artigo Científico
• Fonte: THIRTY-EIGHTH AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOL 38 NO 20; v. N/A, p. 9-pg., 2025-01-01.

Resumo

Correctly assessing the malignancy of breast lesions identified during ultrasound examinations is crucial for effective clinical decision-making. However, the current "gold standard" relies on manual BI-RADS scoring by clinicians, often leading to unnecessary biopsies and a significant mental health burden on patients and their families. In this paper, we introduce PersonalizedUS, an interpretable machine learning system that leverages recent advances in conformal prediction to provide precise and personalized risk estimates with local coverage guarantees and sensitivity, specificity, and predictive values above 0.9 across various threshold levels. In particular, we identify meaningful lesion subgroups where distribution-free, model-agnostic conditional coverage holds, with approximately 90% of our prediction sets containing only the ground truth in most lesion subgroups, thus explicitly characterizing for which patients the model is most suitably applied. Moreover, we make available a curated tabular dataset of 1936 biopsied breast lesions from a recent observational multicenter study and benchmark the performance of several state-of-the-art learning algorithms. We also report a successful case study of the deployed system in the same multicenter context. Concrete clinical benefits include up to a 65% reduction in requested biopsies among BI-RADS 4a and 4b lesions, with minimal to no missed cancer cases. (AU)

• Processo FAPESP: 19/11321-9 - Redes neurais em problemas de inferência estatística
• Beneficiário: Rafael Izbicki
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 23/07068-1 - Aprendizado estatístico de máquina: em direção a uma melhor quantificação de incerteza
• Beneficiário: Rafael Izbicki
• Modalidade de apoio: Auxílio à Pesquisa - Regular